Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway

• Zhiyu Wang ,

  Contributed equally to this work with: Zhiyu Wang, Neng Wang

  Affiliation School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China

  ⨯
• Neng Wang ,

  Contributed equally to this work with: Zhiyu Wang, Neng Wang

  Affiliation School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China

  ⨯
• Shouwei Han,

  Affiliation Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical Collage, University of Guangzhou Traditional Chinese Medicine, Guangzhou, China

  ⨯
• Dongmei Wang,

  Affiliation School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China

  ⨯
• Suilin Mo,

  Affiliation The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

  ⨯
• Linzhong Yu,

  Affiliation School of Chinese Medicine, South Medical University, Guangzhou, China

  ⨯
• Hui Huang,

  Affiliation Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

  ⨯
• Kamchuen Tsui,

  Affiliation The Hong Kong Associate of Chinese Medicine, Hong Kong, China

  ⨯
• Jiangang Shen,

  Affiliation School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China

  ⨯
• Jianping Chen

  * E-mail: jpjpchen@yahoo.com

  Affiliation School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China

  ⨯